TRCT
NBP

Tower Research Capital (TRC)’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Tower Research Capital (TRC)’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.97K Buy
3,241
+1,476
+84% +$4.94K ﹤0.01% 3993
2025
Q4 		$7.03K Buy
+1,765
New +$7.81K ﹤0.01% 4038
2024
Q4 		– Sell
-4,015
Closed -$4.98K – 5834
2024
Q3 		$4.98K Buy
+4,015
New +$5.03K ﹤0.01% 4354
2024
Q1 		– Sell
-24,608
Closed -$46.8K – 5993
2023
Q4 		$46.8K Sell
24,608
-3,510
-12% -$5.24K ﹤0.01% 3171
2023
Q3 		$37.1K Buy
28,118
+20,473
+268% +$45K ﹤0.01% 2832
2023
Q2 		$22.9K Buy
7,645
+2,957
+63% +$9.5K ﹤0.01% 3269
2023
Q1 		$16K Sell
4,688
-1,831
-28% -$8.87K ﹤0.01% 3703
2022
Q4 		$27K Sell
6,519
-62,650
-91% -$237K ﹤0.01% 2836
2022
Q3 		$278K Buy
69,169
+67,388
+3,784% +$511K ﹤0.01% 1617
2022
Q2 		$20K Sell
1,781
-3,407
-66% -$40.8K ﹤0.01% 3789
2022
Q1 		$84K Buy
5,188
+4,227
+440% +$108K ﹤0.01% 2341
2021
Q4 		$46K Sell
961
-1,416
-60% -$85K ﹤0.01% 2822
2021
Q3 		$172K Buy
2,377
+1,551
+188% +$112K ﹤0.01% 1950
2021
Q2 		$69K Buy
826
+126
+18% +$8.31K ﹤0.01% 2752
2021
Q1 		$34K Buy
700
+485
+226% +$26.3K ﹤0.01% 3453
2020
Q4 		$10K Buy
+215
New +$8.47K ﹤0.01% 4312

Other funds holding NBP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACM
AIHC Capital Management Central $120M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Tower Research Capital (TRC)'s NBP Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 84% in Q1 2026, buying an estimated $4.94K and bringing the position to 3,241 shares worth $7.97K. The position accounts for ﹤0.01% of the portfolio, ranked #3993.

Tower Research Capital (TRC) first reported a position in NBP in Q4 2020 and has held it in 16 quarters since. The position peaked at $278K in Q3 2022. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Tower Research Capital (TRC) held 3,241 shares of NovaBridge Biosciences American Depositary Shares worth $7.97K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,476 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $4.94K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3993 holding.
  • Tower Research Capital (TRC) first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and has held it in 16 quarters since.
  • Tower Research Capital (TRC)'s NovaBridge Biosciences American Depositary Shares position peaked at $278K in Q3 2022.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.